The RET proto-oncogene in sporadic pheochromocytomas

Internal Medicine

Volumn 35, Issue 6, 1996, Pages 449-452

  Takaya, Kazuhiko ^a   Yoshimasa, Takaaki ^a   Arai, Hiroshi ^a   Tamura, Naohisa ^a   Miyamoto, Yoshihiro ^a   Itoh, Hiroshi ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Adrenal medulla; c fos; c myc; Gene expression; Mutation

Indexed keywords

DROSOPHILA PROTEIN; ONCOPROTEIN; PROTEIN RET; PROTEIN TYROSINE KINASE; RET ONCOGENE PROTEIN, DROSOPHILA; TUMOR PROTEIN;

ADRENAL MEDULLA; ADRENAL TUMOR; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL TRANSFORMATION; CODON; EXON; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEURAL CREST; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; PROTO ONCOGENE; SIPPLE SYNDROME;

ADRENAL GLAND NEOPLASMS; ADRENAL MEDULLA; ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; CODON; DROSOPHILA PROTEINS; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; NEOPLASM PROTEINS; NEURAL CREST; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0030154859     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.449     Document Type: Article

References (21)

1. Mulligan LM, Kwok JBJ, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458, 1993.
2. Donis-Keller H, Dou S, Chi D. et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851, 1993.
3. Hofstra RMW, Landsvater RM, Ceccherini I, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375, 1994.
4. Takahashi M, Buma Y, Iwamoto T, InagumaY, Ikeda H, Hirai H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3: 571, 1988.
5. Takahashi M, Cooper GM. ret Transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7: 1378, 1987.
6. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42: 581, 1985.
7. Pachnis V, Mankoo B, Costantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119: 1005, 1993.
8. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367: 380, 1994.
9. Santoro M, Carlomagno F, Romano A. et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267: 381, 1995.
10. Zedenius J, Wallin G, Hamberger B, Nordenskjöld M, Weber G, Larsson C. Somatic and MEN2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. Hum Mol Genet 3: 1259, 1994.
11. Eng C, Smith DP, Mulligan LM, et al. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and releated sporadic tumors. Hum Mol Genet 3 (2): 237, 1994.
12. Nagao M, Ishizaka Y, Nakagawara A, et al. Expression of ret proto-oncogene in human neuroblastomas. Jpn J Cancer Res 81: 309, 1990.
13. Santoro M, Rosati R, Grieco M, et al. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5: 1595, 1990.
14. Ikeda I, Ishizaka Y, Tahira T, et al. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines. Oncogene 5: 1291, 1990.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory Manual. 2nd ed. Cold Spring Harbor. New York, 1989.
16. Maeda S, Namba H, Takamura N, et al. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas. Endocr J 42: 245, 1995.
17. Komminoth P, Kunz E, Hiort O, et al. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am J Pathol 145: 922, 1994.
18. Yoshimoto K, Tanaka C, Hamaguchi S. et al. Tumor-specific Mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type. Endocr J 42: 265, 1995.
19. Lindor NM, Honchel R, Khosla S, Thibodeau SN. Mutations in the RET proto-oncogene in sporadic pheochromocytomas. J Clin Endocrinol Metab 80: 627, 1995.
20. Beldjord C, Desclaux-Arramond F, Raffin-Sanson M, et al. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. J Clin Endocrinol Metab 80: 2063, 1995.
21. Miya A, Yamamoto M, Morimoto H, et al. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A. Henry Ford Hosp Med J 40: 215, 1992.